Details for New Drug Application (NDA): 203860
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 203860
Tradename: | SEVELAMER CARBONATE |
Applicant: | Invagen Pharms |
Ingredient: | sevelamer carbonate |
Patents: | 0 |
Pharmacology for NDA: 203860
Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 203860
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 203860 | ANDA | Cipla USA Inc. | 69097-893 | 69097-893-93 | 270 TABLET, FILM COATED in 1 BOTTLE (69097-893-93) |
SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 203860 | ANDA | Cipla USA Inc. | 69097-967 | 69097-967-93 | 270 TABLET, FILM COATED in 1 BOTTLE (69097-967-93) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
Approval Date: | Oct 26, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription